Stay updated on Dapagliflozin in Acute Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Acute Heart Failure Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision number changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check8 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now renders a 403 Forbidden error page, replacing the previous study record content and navigation. This indicates access is blocked rather than displaying the study details.SummaryDifference18%

- Check50 days agoChange DetectedA new publication citation from JACC Heart Fail about in-hospital initiation of dapagliflozin was added, and the page revision was updated to v3.6.6.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5 on the page, indicating a small metadata update to the ClinicalTrials.gov entry rather than a change to study details.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a new build of the page. This is a deployment update and does not appear to alter the study details or how the page is used.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin in Acute Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.